Similar articles

• [Cell kinetics of the bladder carcinoma. III. Changes of the cell cycle following thio-TEPA treatment and possible factors for kinetics of cell killing in cultured human bladder carcinoma cells (author's transl)].

  Kato T, Ishikawa K, Nemoto R. Kato T, et al. Nihon Hinyokika Gakkai Zasshi. 1977 Nov;68(11):1029-35. Nihon Hinyokika Gakkai Zasshi. 1977. PMID: 415167 Japanese. No abstract available.
• Anticancer drug sensitivity in vitro in the bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone and urokinase in bladder cancer.

  Hisazumi H, Uchibayashi T, Katoh M, Kobayashi T, Nakajima K, Naitoh K, Misaki T, Kuroda K. Hisazumi H, et al. Urol Res. 1981;9(5):231-5. doi: 10.1007/BF00256892. Urol Res. 1981. PMID: 7029855
• [Cell kinetics of the bladder carcinoma. II. Effects of thio-TEPA on proliferative kinetics of the cultured human bladder carcinoma cells (author's transl)].

  Kato T. Kato T. Nihon Hinyokika Gakkai Zasshi. 1976 Jul 20;67(7):497-501. Nihon Hinyokika Gakkai Zasshi. 1976. PMID: 823357 Japanese. No abstract available.
• The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.

  Hisazumi H, Uchibayashi T, Naito K, Misaki T, Miyazaki K. Hisazumi H, et al. J Urol. 1975 Sep;114(3):394-8. doi: 10.1016/s0022-5347(17)67038-1. J Urol. 1975. PMID: 806708
• [Pharmacology of fibrinolytics].

  Klöcking HP. Klöcking HP. Z Gesamte Inn Med. 1979 Jan 1;34(1):22-8. Z Gesamte Inn Med. 1979. PMID: 373275 Review. German.